Macular Degeneration Foundation

ARVO 2019: Anneke denHollander PhD

Anneke denHollander, PhDGenetics of Multifactorial Eye DiseasesRadboudUMCARVO 2019 Topic: Risk factors for Fellow Eye Progression in Patients with Age-Related Macular Degeneration

ARVO 2019: Madhu Cherukury PhD

Madhu Cherukury PhDAllgenesis Biotherapeutics Inc.http://www.allgenesis.comARVO 2019 Topic: AG-73305, a Novel Multi-specific Fc-fusion Protein under Development for the Treatment of Diabetic Macular Edema

ARVO 2019: Christopher Moen MD

Christopher Moen MD President Choroideremia Research Foundation http://www.curechm.org Topic: Connecting Researchers and Clinicians to Cope with Vision Loss

ARVO 2019: Gena Harper

Gena Harper Morgan Stanley Wealth Management Senior Vice President-Wealth Management Senior Investment Management Consultant ARVO 2019 Topic: Tips for Thriving with Low Vision & Blindness

ARVO 2019: Valeria Canto-Soler PhD

Valeria Canto-Soler PhD Doni Solich Family Chair in Ocular Stem Cell Research Dir. of CellSight – Ocular Stem Cell and Regeneration Program Associate Professor – Department of Ophthalmology University of Colorado School of Medicine Topic: Retinal transplant to treat Dry AMD http://www.ucdenver.edu

ARVO 2019: Samar Mohanty PhD

Dr. Samar Mohanty, PhD, PresidentRobert Benkowski, Business AdvisorNanoscope TherapeuticsARVO 2019Topic: Gene Therapy Using Light-Sensitive Molecules and Light-Assisted Gene Deliveryhttp://www.nanostherapeutics.comhttp://www.nanoscopetech.com

ARVO 2019: Margaret DeAngelis PhD

Margaret DeAngelis PhDMoran Eye CenterUniversity of UtahARVO 2019 Topic: Processing and Phenotyping Donor Eyes

ARVO 2019: Saghar Bagheri

Saghar Bagheri Research Fellow in Ophthalmology (EXT) Massachusetts Eye and Ear Infirmary Harvard Medical School ARVO – AMDF Travel Award Winner ARVO2019 Topic: Anti-VEGF Non-Responders are often short-term responders

ARVO 2019: Iain Wilson

Iain Wilson, DPHIL Student University of Oxford Nuffield Department of Neurosciences http://www.ndcn.ox.ac.uk OxSight http://www.oxsight.co.uk ARVO 2019 Topic: Technology enhancing face recognition for AMD

ARVO 2019: Mike H. Farkas PhD

Michael H. Farkas, Ph.D.Department of OphthalmologyJacobs School of Medicine and Biomedical SciencesState University of New York at Buffalo Topic: The role of RNA splicing factors in retinal degeneration

ARVO 2019: Mark Butler

Mark C Butler Custom colLABorators http://www.customcollaborators.com (716) 725-5781 ARVO 2019 Topic: Developing customized tools and services for the scientific community

ARVO 2019: Susanna Soon-Chun Park MD PhD

Susanna Soon-Chun Park, M.D., Ph.D. UC Davis Health https://health.ucdavis.edu Topic: Exploring Bone Marrow Stem Cells for Retinal Regeneration

ARVO 2019: Amany Tawfik MD

Amany Tawfik, MDAugusta UniversityJames and Jean Culver Vision Discovery Institute http://www.augusta.eduhttp://www.culvervdi.org Topic: The impact of increased levels of amino acid homocysteine and its role in inducing Blood retinal barrier dysfunction in AMD

ARVO 2019: Neena Haider PhD

Harvard Medical SchoolSchepens Eye Research Institute of Massachusetts Eye and Ear Topic: Gut Biome In Relation to Eye Disease

ARVO 2019: Amir H. Kashani MD PhD

USC Roski Eye Institute Keck School of Medicine USC https://keck.usc.edu https://eye.keckmedicine.org/ Topic: Stem-cell based therapy for dry AMD

ARVO 2019: Kimberly Gokoffski MD PhD

Kimberly Gokoffski MD PhDAssistant Professor of Clinical OphthalmologyUSC Roski Eye InstituteKeck Medicine of USC Topic: Electrical stimulation to regenerate the optic nerve re-establishing vision by connecting the eye to the brain

ARVO 2019: Praveen Gupta OD PhD

Praveen Gupta OD PhD UTMB HealthThe University of Texas Medical Branch Topic: Histochemical Characterization of Drusen Related Pathology in Age Related Macular Degeneration

Harvard 2018: Jonathan B Lin

Washington University School of Medicine Apte Lab https://ophthalmology.wustl.edu/ Topic: Macrophage MicroRNA-150 Promotes Pathological Angiogenesis as seen in AMD

Harvard 2018: Anders Naar, PhD

University of California, Berkeley Metabolic Biology Department of Nutritional Sciences & Toxicology https://nst.berkeley.edu Topic: Cholesterol Lipid Regulation and AMD

Harvard 2018: Deborah Ferrington, PhD

Dept. of Ophthalmology and Visual Neurosciences University of Minnesota http://www.ophthalmology.umn.edu Topic: Mitochondrial dysfunction in the retinal pigment epithelium promotes AMD pathology

Harvard 2018: Andrew Dick, MD

Andrew Dick, MD Bristol Eye Hospital, University of Bristol http://www.bristol.ac.uk/medical-school/research/translational-health-sciences/ UCL Institute of Ophthalmology http://www.ucl.ac.uk Topic: Immunotherapy regulating immune responses through metabolic sensing

Harvard 2018: Joan W Miller, MD

Joan W Miller, MDProfessor of Ophthalmology – David Glendenning Cogan Chief of Ophthalmology – Mass Eye and Ear and Mass General HospitalChair, Dept. of Ophthalmology Harvard Medical School Topic: Current research on Early/Dry AMD

Harvard 2018: Goldis Malek PhD

Goldis Malek, PhDDuke Eye CenterDuke University School of Medicinehttps://dukeeyecenter.duke.edu/researchhttps://pathology.duke.edu/research/s…https://dukeeyecenter.duke.edu/about/… Presentation: Rethinking Nuclear Receptors as Therapeutic Targets for AMD

Harvard 2018: Aparna Lakkaraju PhD

Aparna Lakkaraju, PhD Department of Ophthalmology University of California, San Francisco http://ophthalmology.ucsf.edu/lakkara… Presentation: Intracellular Complement Activation in the Retinal Pigment Epithelium

ARVO 2018: Dr. Felicity de Cogan

EXCLUSIVE INTERVIEW: University of Birmingham Institute of Microbiology and Infection Royal Academy of Engineering Enterprise Fellow Topical treatment for AMD http://www.birmingham.ac.uk/microbiology-infection Presentation: Non-invasive delivery and efficacy of ranibizumab and bevacizumab in rabbit and porcine eyes MacRegen http://www.macregen.com

ARVO 2018: Nathan Hotaling PhD

Nathan Hotaling PhD National Eye Institute Biomaterials Group . Presentation: Training to Improve Precision and Accuracy in the Measurement of Fiber Morphology

ARVO 2018: Sudha Iyengar PhD

Sudha K. Iyengar PhD Professor – Vice Chair for Research Case Western Reserve University http://epbiwww.case.edu/ . Presentation: Identification of genes for Age-Related Macular Degeneration

ARVO 2018: Neena Haider PhD

Neena Haider PhD Associate Professor of Ophthalmology Harvard Medical School Schepens Eye Research Institute Massachusetts Eye and Ear . Presentation: Genetic modifier to ameliorate more than one form of inherited retinal degeneration & Unique genetic models to study the retinal and vascular phenotypes associated with AMD . http://www.masseyeandear.org http://www.schepens.harvard.edu/ http://www.hms.harvard.edu

ARVO 2018: Claus von der Burchard MD

Claus von der Burchard MD Universitatsklinikum Schleswig-Holstein University Eye clinic . Presentation: At Home OCT Scan and monitoring

ARVO 2018: Nanoscope Therapeutics

Nanoscope Therapeutics Samarendra Mohanty, Founder-President Sulagna Bhattacharya, CEO Nanoscope Therapeutics Inc. http://www.nanostherapeutics.com . Presentation: Targeted Gene Therapy

Select any channel below to view all posts within that channel: